Jiancheng Lv
No. 300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
EP300-Mediated MTF1-K218 Lactylation Buffers AR-Driven Copper Overload to Suppress Cuproptosis in Castration-Resistant Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 07, 2026
HDAC10 suppresses anti-tumour immunity by inhibiting ILF3-CXCL9 axis to block CD8+ T cell infiltration and activation in bladder cancer.
Journal: Cancer letters
Published: December 05, 2025
Histone deacetylase HDAC7 restricts CD8 + T cell tumor infiltration and limits immunotherapy sensitivity in bladder cancer: reversal by pinocembrin.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 30, 2025
N6-methyladenosine-modified RNF220 induces cisplatin resistance and immune escape via regulating PDE10A K48-linked ubiquitination in bladder cancer.
Journal: Biochemical pharmacology
Published: December 29, 2024
Tumor suppressing function of SLC16A7 in bladder cancer and its pan-cancer analysis.
Journal: BMC cancer
Published: December 09, 2024
Inhibition of SIRT4 promotes bladder cancer progression and immune escape via attenuating CD8+ T cells function.
Journal: International immunopharmacology
Published: November 04, 2024
SRSF1-mediated alternative splicing regulates bladder cancer progression and cisplatin sensitivity through HIF1A/BNIP3/mitophagy axis.
Journal: Journal of translational medicine
Published: October 23, 2024
IGF2BP3 promotes the proliferation and cisplatin resistance of bladder cancer by enhancing the mRNA stability of CDK6 in an m6A dependent manner.
Journal: International journal of biological sciences
Published: September 11, 2024
Membrane palmitoylated protein MPP1 inhibits immune escape by regulating the USP12/ CCL5 axis in urothelial carcinoma.
Journal: International immunopharmacology
Published: September 10, 2024
CircFAM64A(3) promoted bladder cancer proliferation and inhibited CD8 + T cell via sponging to miR-149-5p and activated IL-6/JAK/STAT pathway.
Journal: International immunopharmacology
Published: August 07, 2024
CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2/CD36 pathway.
Journal: International immunopharmacology
Published: April 24, 2024
Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade.
Journal: International journal of biological sciences
Published: June 15, 2023
Last Updated: 09/26/2026